Reporting owner · CIK 0002129436
Baumann Oliver Rolf
Visual SEC Form 4 history across 1 companies, 1 transactions and 1 filings.
DIRVeraxa Biotech AG - Post de-SPAC
Open-market mix
100%buys
Open-market buy performance
90-day forward return on this insider's open-market purchases
Forward return is not available yet
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for some of their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
Net value flow
Buys minus sells
Aug 26
$75K
Transaction texture
Ownership and ticket size
Average P/S size$75K
Median P/S size$75K
Direct0
Indirect1
Aug 27, 2026buy
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Latest transaction
buy at Veraxa Biotech AG - Post de-SPAC on Aug 27, 2026 valued at $75,000.
Review SEC filingLatest buy
buy at Veraxa Biotech AG - Post de-SPAC on Aug 27, 2026 valued at $75,000.
Review SEC filingLatest sale
No open-market insider sale is available.
Associated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| VRXA | Baumann Oliver Rolf | DIR | buy | 50.0k | $7.50M | P | — | 08/31 | 08/27 |
Baumann Oliver Rolf Insider Activity FAQ
SEC Form 4 context
Who is Baumann Oliver Rolf?
Baumann Oliver Rolf is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002129436.
Which companies has Baumann Oliver Rolf reported transactions for?
Veraxa Biotech AG - Post de-SPAC
When was Baumann Oliver Rolf's latest insider buy?
buy at Veraxa Biotech AG - Post de-SPAC on Aug 27, 2026 valued at $75,000.
When was Baumann Oliver Rolf's latest insider sale?
No open-market insider sale is available for this period.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.